Pfizer and BioNTech have offered to supply SA with their Covid-19 vaccine at a discounted $10 a dose, yet the president’s office still describes the cost as prohibitive, according to a person familiar with the talks.

The price was worked out according to SA’s status as a middle-income nation and is about half what the drugmakers are charging in the US, the person said, asking not to be identified as the information hasn’t been made public...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.